Autolus Therapeutics plc American Depositary Share (AUTL) is a publicly traded Healthcare sector company. As of May 21, 2026, AUTL trades at $1.65 with a market cap of $479.06M and a P/E ratio of -1.48. AUTL moved -0.31% today. Year to date, AUTL is -12.90%; over the trailing twelve months it is +5.88%. Its 52-week range spans $1.11 to $5.00. Analyst consensus is strong buy with an average price target of $8.08. Rallies surfaces AUTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own AUTL include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Autolus Therapeutics plc American Depositary Share.
| Metric | Value |
|---|---|
| Price | $1.65 |
| Market Cap | $479.06M |
| P/E Ratio | -1.48 |
| EPS | $-1.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.00 |
| 52-Week Low | $1.11 |
| Volume | 1.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $92.62M |
| Net Income | $-288.96M |
| Gross Margin | -11.19% |
6 analysts cover AUTL: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.08.